因素 | non-HF组(N = 103) | HF组(N = 103) | P值 |
性别(男/女) | 49/54 | 64/39 | 0.069 |
年龄(岁) | 68.17 ± 5.58 | 70.39 ± 10.66 | 0.063 |
BMI (kg/m2) | 23.60 ± 3.52 | 24.35 ± 3.74 | 0.141 |
MAP (mmHg) | 90.28 ± 9.54 | 92.58 ± 11.88 | 0.126 |
总胆固醇(mmol/L) | 4.79 ± 1.00 | 3.69 ± 1.03* | 0.000 |
甘油三酯(mmol/L) | 1.26 (0.96, 1.90) | 0.91 (0.74, 1.31)* | 0.000 |
HDL-C (mmol/L) | 1.18 ± 0.27 | 0.97 ± 0.25* | 0.000 |
LDL-C (mmol/L) | 2.79 ± 0.69 | 2.18 ± 0.74* | 0.000 |
载脂蛋白A1 (g/L) | 1.35 ± 0.20 | 1.08 ± 0.24* | 0.000 |
载脂蛋白B (g/L) | 0.97 ± 0.24 | 0.84 ± 0.34* | 0.001 |
ALT (U/L) | 14.74 (11.93, 22.3) | 18.09 (15.37, 20.45) | 0.717 |
AST (U/L) | 14.81 (10.23, 27.00) | 20.87 (16.91, 26.35)* | 0.000 |
肌酐(mmol/L) | 66.42 ± 11.98 | 82.07 ± 18.17* | 0.000 |
尿素氮(mmol/L) | 6.58 ± 1.81 | 7.07 ± 2.32 | 0.069 |
空腹血糖(mmol/L) | 5.24 ± 0.98 | 6.24 ± 2.07* | 0.000 |
糖化血红蛋白(%) | 5.82 ± 1.36 | 6.57 ± 1.48* | 0.000 |
NT-ProBNP (ng/L) | 63.87 (30, 102.5) | 1239.16 (518, 3535)* | 0.000 |
室间隔厚度(mm) | 8.54 ± 1.11 | 9.53 ± 1.58* | 0.000 |
左室后壁厚度(mm) | 8.46 ± 1.07 | 9.17 ± 1.1* | 0.000 |
左房内径(mm) | 34.49 ± 3.87 | 44.48 ± 7.72* | 0.000 |
LVEDD (mm) | 45.21 ± 3.90 | 52.55 ± 8.63* | 0.000 |
E/A | 0.99 ± 0.34 | 1.15 ± 0.71 | 0.058 |
E/e¢ | 8 (7, 10) | 13 (11, 18)* | 0.000 |
LVEF (%) | 61.09 ± 2.51 | 43.5 ± 13.35* | 0.000 |
糖尿病患病率 | 12 (11.7%) | 42 (40.8%)* | 0.036 |
高血压患病率 | 35 (34%) | 83 (80.6%)* | 0.000 |
冠心病患病率 | 6 (5.8%) | 86 (83.5%)* | 0.000 |
达格列净 | 7 (6.8%) | 29 (28.2%)* | 0.000 |
抗血小板类 | 6 (5.8%) | 43 (41.7%)* | 0.000 |
他汀类 | 28 (27.2%) | 82 (79.6%)* | 0.000 |
ACEI/ARB/ARNI | 20 (19.4%) | 74 (71.8%)* | 0.000 |
β受体阻滞剂 | 13 (12.6%) | 82 (79.6%)* | 0.000 |
钙离子阻滞剂 | 11 (0.7%) | 26 (25.2%)* | 0.006 |
利尿剂 | 2 (1.9%) | 93 (90.3%)* | 0.000 |
硝酸酯类 | 1 (1%) | 35 (34%)* | 0.000 |
SGK1 (ng/mL) | 0.24 (0.19, 0.29) | 0.32 (0.20, 0.52)* | 0.000 |